Using a Novel Measuring Device to Objectively Evaluate the Clinical Benefit on Ptosis in Infantile-Onset Pompe Disease (IOPD): Results from 145 Weeks' Avalglucosidase Alfa Dosing in Mini-COMET Participants Previously Treated with Alglucosidase Alfa
Molecular Genetics and Metabolism（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined